Check Screen Reader Mode to make this survey compatible with screen readers.
Check Screen Reader Mode to make this survey compatible with screen readers.

Survey: Corneal Endothelial Disease

Thank you for taking this survey for diagnosis and treatment of corneal endothelial disease. Your opinions and insights will help guide Aurion Biotech in its clinical development. This survey should only take 3 minutes of your time. Your individual responses will be kept strictly confidential.
1.Are you an:(Required.)
2.How frequently do you diagnose patients with:(Required.)
1-2 patients per week (or more)
1-2 patients per month
1-2 patients per quarter
1-2 patients per year (or fewer)
Corneal endothelial dystrophies (i.e., Fuchs Dystrophy, PPMD, CHED)
Post-surgical Endothelial Dysfunction (i.e., Pseudophakic Corneal Edema, Bullous Keratopathy, Secondary to Glaucoma Tube Shunts, etc.)
Other causes of endothelial dysfunction (Primary/Secondary Corneal Graft Failure, Endotheliitis, TASS, etc.)
3.Please rate your level of agreement to each of the following, from strongly disagree to strongly agree. When I make a diagnosis:(Required.)
Strongly Disagree
Somewhat Disagree
Somewhat Agree
Strongly Agree
N/A
If the disease is mild (i.e., BCVA 20/30 or better/ BAT 20/40 or better), I would counsel the patient to “watchful waiting” in the near term
If disease is moderate (i.e., BCVA 20/30 – 20/60/ BAT 20/60 or worse), I would refer the patient to a corneal specialist for further assessment
If disease is moderate to severe (i.e., BCVA 20/70 or worse/ BAT 20/80 or worse), I would refer the patient to a corneal specialist for assessment and evaluation for potential surgery
If disease is moderate to severe (i.e., BCVA worse than 20/80), I would likely recommend surgical management
4.What is your opinion of current standard of care: Endothelial Keratoplasty? Please rate your level of agreement to the following (1 = Strongly disagree --> 4 = strongly agree, 5 = N/A):(Required.)
DSAEK
DMEK
Restores vision to patients with mild to moderate endothelial disease and has excellent outcomes
Restores vision to patients with moderate to severe endothelial disease and has excellent outcomes
It’s an invasive procedure for patients, with a long recovery time lying flat on their back for up to 3 days
It’s a difficult procedure to perform, and may require regrafts or other secondary surgical interventions
It’s a time-consuming procedure (30-60 minutes)
I don’t know that much about it, since I don’t perform this procedure, nor manage patients with these diseases
5.Are you aware of the corneal endothelial cell therapy procedure research from Japan (Kyoto Prefecture University and Professor Shigeru Kinoshita)?(Required.)
Current Progress,
0 of 10 answered
Privacy & Cookie Notice